Potential treatments for epigenetic dysregulation in neurological diseases

Potential treatments for epigenetic dysregulation in neurological diseases

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Opis bibliograficzny
1. autor:	Zaman, Rubaiyat
Kolejni autorzy:	Sharmin, Sabrina
Format:	Praca dyplomowa
Język:	English
Wydane:	Brac University 2024
Hasła przedmiotowe:	Epigenetics Methylation Parkinson’s disease Alzheimer’s disease Huntington’s disease Acetylation Nervous System Diseases Epigenesis
Dostęp online:	http://hdl.handle.net/10361/23157

Podobne zapisy

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
od: Mostofa, Golam
Wydane: (2022)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
od: Dey, Manashi
Wydane: (2024)

Role of epigenetics in the development of metabolic disorders: a review
od: Mita, Tanzia Mohsin
Wydane: (2024)

Role of circular RNA in neurological disease
od: Salsabil, Labiba
Wydane: (2024)

Gene editing for neurodegenerative diseases-A review
od: Sharna, Anika Islam
Wydane: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
od: Alim, Abdul
Wydane: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
od: Annee, Israt Jahan
Wydane: (2023)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
od: Afsana, Nourin
Wydane: (2022)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
od: Chowdhury, Sariya Uzrat
Wydane: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
od: Ferdous, Labiba
Wydane: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
od: Bakar, Osama Bin Abu
Wydane: (2024)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
od: Tabassum, Nadira
Wydane: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
od: Islam, Md. Irfath
Wydane: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
od: Shehab, Habibul Mohsin
Wydane: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
od: Afreen, Nuraia
Wydane: (2021)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
od: Karmaker, Swastika
Wydane: (2024)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
od: Key, Nasrin Sultana
Wydane: (2023)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
od: Tamanna, Mst. Taskia
Wydane: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
od: Tasneem, Sadia
Wydane: (2021)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
od: Ishrat, Nowshin
Wydane: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
od: Saha, Bithi Rani
Wydane: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
od: Chowdhury, Amal
Wydane: (2024)

A review on cardiovascular development and epigenetics
od: Srity, Nafisa Alam
Wydane: (2024)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
od: Hassan, Md. Muhtaz
Wydane: (2020)

Marine compounds in the treatment of Alzheimer’s disease
od: Parveen, Sanjana
Wydane: (2022)

Alzheimer's disease and marriage : an intimate account /
od: Wright, Lore K.
Wydane: (1993)

Review on: the mechanism and function of Glia in parkinson's disease
od: Abedin, Khondokar Mezbahul
Wydane: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
od: Tasin, Md Abtahi
Wydane: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
od: Aziz, Farhin
Wydane: (2019)

Infection and communicable diseases /
od: Brettle, Raymond Patrick
Wydane: (1984)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
od: Afra, Sumaiya
Wydane: (2022)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
od: Mahee, Sadique Abdal
Wydane: (2024)

Early detection of parkinson’s disease using image processing and artificial neural network
od: Rumman, Mosarrat, i wsp.
Wydane: (2018)

Cerebrovascular and neurological dysfunction as a result of COVID-19 infection in patients with migraine
od: Rawshan, A. E. Maisha
Wydane: (2022)

A study on less explored plants with potential neuroprotective activity against neurodegenerative diseases
od: Nayeem, Abdullah Al
Wydane: (2021)

Control of communicable diseases manual : an official report of the American Public Health Association /
Wydane: (1995)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
od: Islam, Md. Rakibul
Wydane: (2023)

Clinical Infectious Diseases

The Journal of Infectious Diseases

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
od: Halim, Rabea
Wydane: (2022)